Ras-PI3K pathway promotes osteosarcoma progression via regulating VRK1-mediated H2A phosphorylation at threonine 120

References

• Marina N, Gebhardt M, Teot L, et al. Biology and therapeutic advances for pediatric osteosarcoma. The Oncol. 2004;9(4):422–441.
   PubMed Web of Science ®Google Scholar
• Gajewska J, Ambroszkiewicz J, Chelchowska M, et al. PS-094 the levels of bone alkaline phosphatase and human epidermal growth factor receptor-2 in patients with osteosarcoma. Arch Dis Child. 2014;99(2):A144.
   Google Scholar
• Tsubaki M, Yamazoe Y, Yanae M, et al. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-beta as angiogenic factors in mouse osteosarcoma. Cytokine. 2011;54(1):100–107.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu XH, Yan YG, et al. PI3K/Akt signaling in osteosarcoma. Clinica Chimica Acta: Int J Clin Chem. 2015;444:182–192.
   PubMed Web of Science ®Google Scholar
• Murillo MM, Zelenay S, Nye E, et al. RAS interaction with PI3K p110alpha is required for tumor-induced angiogenesis. J Clin Invest. 2014;124(8):3601–3611.
   PubMed Web of Science ®Google Scholar
• Sheridan C, Downward J. Inhibiting the RAS-PI3K pathway in cancer therapy. Enzymes. 2013;34:107–136.
   PubMedGoogle Scholar
• Wu CL, Tsai HC, Chen ZW, et al. Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma. Cell Signal. 2013;25(12):2812–2822.
   PubMed Web of Science ®Google Scholar
• Chrun ES, Modolo F, Daniel FI. Histone modifications: a review about the presence of this epigenetic phenomenon in carcinogenesis. Pathol, Res Pract. 2017;213(11):1329–1339.
   PubMed Web of Science ®Google Scholar
• Izzo A, Schneider R. The role of linker histone H1 modifications in the regulation of gene expression and chromatin dynamics. Biochimica et Biophysica Acta. 2016;1859(3):486–495.
   PubMed Web of Science ®Google Scholar
• Cavalcanti MC, Rizgalla M, Geyer J, et al. Expression of histone 1 (H1) and testis-specific histone 1 (H1t) genes during stallion spermatogenesis. Anim Reprod Sci. 2009;111(2–4):220–234.
   PubMed Web of Science ®Google Scholar
• Wanner G, Schroeder-Reiter E, Ma W, et al. The ultrastructure of mono- and holocentric plant centromeres: an immunological investigation by structured illumination microscopy and scanning electron microscopy. Chromosoma. 2015;124(4):503–517.
   PubMed Web of Science ®Google Scholar
• Kim K, Kim JM, Kim JS, et al. VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription. Mol Cell. 2013;52(3):459–467.
   PubMed Web of Science ®Google Scholar
• Aihara H, Nakagawa T, Mizusaki H, et al. Histone H2A T120 phosphorylation promotes oncogenic transformation via upregulation of cyclin D1. Mol Cell. 2016;64(1):176–188.
   PubMed Web of Science ®Google Scholar
• Li J, Wang T, Pei L, et al. Expression of VRK1 and the downstream gene BANF1 in esophageal cancer. Biomed Pharmacother: Biomed Pharmacother. 2017;89:1086–1091.
   PubMed Web of Science ®Google Scholar
• Mon AM, MacKinnon AC Jr, Traktman P. Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells. PLoS One. 2018;13(9):e0203397.
   PubMed Web of Science ®Google Scholar
• Molitor TP, Traktman P. Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo. Oncogenesis. 2013;2(6):e48.
   PubMed Web of Science ®Google Scholar
• Billiau A, Edy VG, Heremans H, et al. Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother. 1977;12(1):11–15.
   PubMed Web of Science ®Google Scholar
• Heldin CH, Johnsson A, Wennergren S, et al. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature. 1986;319(6053):511–514.
   PubMed Web of Science ®Google Scholar
• Dalby B, Cates S, Harris A, et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods (San Diego, Calif). 2004;33(2):95–103.
   PubMed Web of Science ®Google Scholar
• Ish-Shalom S, Lichter A. Analysis of fungal gene expression by real time quantitative PCR. Methods Mol Biol. 2010;638:103–114.
   PubMedGoogle Scholar
• Kong L, Wang X, Zhang K, et al. Gypenosides synergistically enhances the anti-tumor effect of 5-fluorouracil on colorectal cancer in vitro and in vivo: a role for oxidative stress-mediated DNA damage and p53 activation. PLoS one. 2015;10(9):e0137888.
   PubMed Web of Science ®Google Scholar
• Horibata S, Vo TV, Subramanian V, et al. Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells. JoVE. 2015;99:e52727.
   Google Scholar
• Zhang H, Li H, Liu Z, et al. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138. J Cell Biochem. 2018;119(12):9866–9877.
   PubMed Web of Science ®Google Scholar
• Luo H, Shenoy AK, Li X, et al. MOF acetylates the histone demethylase LSD1 to suppress epithelial-to-mesenchymal transition. Cell Rep. 2016;15(12):2665–2678.
   PubMed Web of Science ®Google Scholar
• Broadhead ML, Clark JC, Myers DE, et al. The molecular pathogenesis of osteosarcoma: a review. Sarcoma. 2011;2011:1.
   Google Scholar
• Martini M, De Santis MC, Braccini L, et al. PI3K/AKT signaling pathway and cancer: an updated review. Annal Med. 2014;46(6):372–383.
   Web of Science ®Google Scholar
• Tsubaki M, Satou T, Itoh T, et al. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway. Toxicol Appl Pharmacol. 2012;259(3):402–410.
   PubMed Web of Science ®Google Scholar
• Wang T, Gong X, Jiang R, et al. Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell. Am J Trans Res. 2016;8(2):968–980.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang DL, Chen S, et al. Oncogene Ras/phosphatidylinositol 3-kinase signaling targets histone H3 acetylation at lysine 56. J Biol Chem. 2012;287(49):41469–41480.
   PubMed Web of Science ®Google Scholar
• Li Y, Sun D, Sun W, et al. Ras-PI3K-AKT signaling promotes the occurrence and development of uveal melanoma by downregulating H3K56ac expression. J Cell Physiol. 2019;234(9):16032–16042.
   PubMed Web of Science ®Google Scholar
• Sang B, Sun J, Yang D, et al. Ras-AKT signaling represses the phosphorylation of histone H1.5 at threonine 10 via GSK3 to promote the progression of glioma. Artific Cells, Nanomed, Biotechnol: An Int J. 2019;47(1):2882–2890.
   PubMed Web of Science ®Google Scholar
• Castillo J, Lopez-Rodas G, Franco L. Histone post-translational modifications and nucleosome organisation in transcriptional regulation: some open questions. Adv Exp Med Biol. 2017;966:65–92.
   PubMedGoogle Scholar
• Kireeva ML, Mo FE, Yang GP, et al. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol. 1996;16(4):1326–1334.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Samowitz W, Curtin K, et al. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol, Biomark Prevent. 2004;13(7):1206–1214.
   PubMed Web of Science ®Google Scholar
• Al-Zahrani A, Sandhu MS, Luben RN, et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Human Mol Genet. 2006;15(1):1–10.
   PubMed Web of Science ®Google Scholar
• Johnson LM, Price DK, Figg WD. Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy: implications for potential use of inhibitors in cancer treatment. Cancer Biol Ther. 2013;14(2):90–91.
   PubMed Web of Science ®Google Scholar
• Xiong L, Wen Y, Miao X, et al. NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer. Cell Tissue Res. 2014;355(2):365–374.
   PubMed Web of Science ®Google Scholar
• Costa VL, Henrique R, Danielsen SA, et al. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples. Clin Cancer Res: Offic J Am Assoc Cancer Res. 2010;16(23):5842–5851.
   PubMed Web of Science ®Google Scholar
• Karasawa T, Kawashima A, Usui F, et al. Oligomerized CARD16 promotes caspase-1 assembly and IL-1beta processing. FEBS Open Bio. 2015;5(1):348–356.
   PubMed Web of Science ®Google Scholar
• Lopez-Borges S, Lazo PA. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene. 2000;19(32):3656–3664.
   PubMed Web of Science ®Google Scholar
• Liu ZC, Cao K, Xiao ZH, et al. VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma. Oncotarget. 2017;8(39):65642–65658.
   PubMedGoogle Scholar
• Huang W, Cui X, Chen Y, et al. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma. Pathol, Res Pract. 2016;212(3):171–178.
   PubMed Web of Science ®Google Scholar